Report Materials
Of the $200,000 of costs that Syntrix Biosystems, Inc., claimed against the Recovery Act grant, the entire amount was unallowable.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.